GH Research (GHRS) Reports Q3 Net Loss of $1.8M, Cash Position of $280.7M, Issues Business Updates

Go back to GH Research (GHRS) Reports Q3 Net Loss of $1.8M, Cash Position of $280.7M, Issues Business Updates

GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates

December 6, 2021 7:10 AM EST

DUBLIN, Ireland, Dec. 06, 2021 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the third quarter ended September 30, 2021 and gave updates on its business.

Third Quarter 2021 Financial Results

Cash... More